TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›CIGI
CIGI logo

CIGI

Colliers International Group Inc.

Next earnings Jul 29, 2026 · consensus $1.85 EPS, $1.55B rev

Hold
$98.51
▲ +6.18%
$98.51▼ -24.52%
over 1Y
L $88.81H $169.12
Today+6.2%
1W+10.9%
1M+1.9%
3M-8.4%
YTD-32.2%
1Y-24.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C+
Valuation
Overvalued
Filings
Clean
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 14 analysts
Buy

Colliers is growing fast (revenue +15%) and shifting toward recurring investment management, but 45x GAAP EPS — depressed by heavy amortization — leaves it richly priced.

Revenue $5.56B · FY2025

The read

Middling fundamentals and a rich price (~69% above fair value) leave little margin of safety — a wait-and-see.

Colliers is a global commercial real estate services and investment-management firm, and FY2025 showed the franchise re-accelerating: revenue grew 15.3% to $5.56B, the fastest growth in the visible history (up from $4.09B in FY2021), as transactional brokerage recovered and the higher-margin, recurring investment-management and outsourcing/advisory businesses scaled. Operating income was $371M and the company generated $330M of operating cash flow with a healthy 14.6% return on equity. Net income was roughly flat at $225M (-5.2%).

The headline valuation is misleading. Diluted EPS of $2.02 (down 37.3% even as net income barely fell) and the resulting 45.2x P/E are distorted by Colliers' structure: heavy acquisition-driven amortization and depreciation ($256M, +15.5%), substantial non-controlling interests, and convertible/long-term-incentive arrangements all weigh on GAAP per-share earnings. The 0.5x price/sales and the strong cash flow are more telling — Colliers is conventionally valued on adjusted EBITDA, and on that basis the business is far from the 45x the GAAP P/E implies. (Note: the filing narrative attached to this data is from a stale 2003 report describing the predecessor company and is not relevant to today's Colliers; this analysis relies solely on the FY2025 figures.)

Is CIGI a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~90d expiry
  • Long 100 shares @ ~98.51
  • Short call 103 @ ~4.67 est
debit $9,384max +$916max −$9,383BE 93.84

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$4.09B$4.46B$4.34B$4.82B$5.56B
Gross profit—————
Operating income-$132M$332M$301M$389M$371M
Net income-$238M$195M$145M$237M$225M
Diluted EPS-$9.09$1.05$1.41$3.22$2.02
Net margin-5.8%4.4%3.3%4.9%4.0%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$6.46B
EV / EBITDA10.3
EV / Sales1.2
EV / FCF25.7
P / FCF20.0
PEG (trailing)—
Earnings yield4.5%
FCF yield5.0%

Quality & risk

ROIC (est.)9.2%
Free cash flow$251M
Total debt$1.64B
Net cash-$1.43B
Piotroski F-Score6/8

Capital returns

Buyback yield0.6%
Dividend yield (est.)0.3%
Shareholder yield0.9%
Shares Δ YoY+1.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. SC 13D/A Activist / 5%+ stake change2024-03-01
  2. SC 13D/A Activist / 5%+ stake change2022-02-28
  3. SC 13D/A Activist / 5%+ stake change2021-09-20
  4. SC 13D/A Activist / 5%+ stake change2021-05-28
  5. SC 13D/A Activist / 5%+ stake change2021-04-20
  6. SC 13D/A Activist / 5%+ stake change2021-03-03
  7. SC 13D/A Activist / 5%+ stake change2020-03-31
  8. SC 13D/A Activist / 5%+ stake change2020-03-30
  9. SC 13D Activist / 5%+ stake change2017-12-19

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-05-272026-05-27open ↗SCHEDULE 13G/AFiling2026-05-15open ↗6-KPeriod ending 2026-05-132026-05-13open ↗6-KPeriod ending 2026-05-112026-05-11open ↗6-KPeriod ending 2026-03-312026-05-08open ↗6-KPeriod ending 2026-05-052026-05-05open ↗SCHEDULE 13GFiling2026-05-01open ↗SCHEDULE 13DFiling2026-04-06open ↗EFFECTFiling2026-04-02open ↗6-KPeriod ending 2026-03-312026-03-31open ↗F-XFiling2026-03-27open ↗F-10Filing2026-03-27open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueC+
GrowthC
ProfitabilityC+
Financial healthA-
MomentumF
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗P/E below 25

Fair value est.

$30.77

Overvalued -69% vs price

cheapfair valueexpensive

Modified Graham: EPS $2.02 × (8.5 + 1.5 × 5.0% growth) × 0.95 quality = 15.2× multiple. An estimate, not a price target.

88.6752-week168.85
Revenue
$5.56B
+15.3% YoY
Net margin
4.0%
ROE
14.6%
P/E
48.8

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$5.56B+15.3%
Net income$225M-5.2%
Operating income$371M-4.7%
Diluted EPS$2.02-37.3%
Cash & equivalents$208M+18.0%
Total assets$6.79B+11.3%
Stockholders' equity$1.53B+15.7%
Op.: 6.7%

Frequently asked

Is Colliers International Group Inc. (CIGI) a buy?
CIGI currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Colliers is growing fast (revenue +15%) and shifting toward recurring investment management, but 45x GAAP EPS — depressed by heavy amortization — leaves it richly priced.
What is CIGI's fair value?
A Modified-Graham model based on CIGI's SEC fundamentals estimates a fair value of about $30.77. It is an estimate from reported earnings, not a price target.
Is CIGI overvalued or undervalued?
Against a Modified-Graham fair-value estimate, CIGI currently appears overvalued relative to its SEC-grounded earnings power.
What is Colliers International Group Inc.'s quality score?
CIGI scores 61.21549338902905/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000913353, latest 10-Q filed 2004-02-13) · EODHD · Proprietary analysis · as of 6/21/2026, 9:03:36 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 5:03 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2021-05-19
Spruce House Partnership LLC
10% owner
Sell1.50M @ $102.63$154M
2020-03-20
Spruce House Partnership LLC
10% owner
Sell260K @ $46.47$12.1M
2019-12-09
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy1.00 @ $73.74$73.74
2017-02-14
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy65.1K @ $38.28$2.49M
2017-02-09
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy52.7K @ $38.28$2.02M
2016-11-03
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy22.1K @ $35.85$791K
2016-11-03
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy25.0K @ $35.86$897K
2016-11-02
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy37.3K @ $35.88$1.34M
2016-11-02
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy46.1K @ $35.87$1.65M
2016-11-01
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy162K @ $35.33$5.72M
2016-11-01
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy212K @ $35.72$7.59M
2016-10-31
SPRUCE HOUSE PARTNERSHIP LP
10% owner
Buy30.0K @ $34.65$1.04M

Held by tracked funds

Form 13F · SEC · quarterly
Renaissance Technologies485K sh$51.8M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score61 vs 67
Revenue growth15.3% vs 7.5%
Net margin4.0% vs 10.0%
Return on equity14.6% vs 12.0%
P/E48.8 vs 26.2